# Moderna QA & Software Testing - DEEP INSIDER INTEL

**Research Date:** February 22, 2026
**Research Scope:** Comprehensive quality engineering, automation testing, digital transformation, and platform modernization at Moderna
**Compiled for:** Rob Gorham, BDR at Testsigma

---

## 1. MODERNA'S AI & DIGITAL TRANSFORMATION STRATEGY (2024-2026)

### Strategic Foundation: AI-Driven Reorganization

**May 2025 Organizational Merge - Critical Insight:**
Moderna merged HR and IT under a single leader—a structural signal of strategic intent. This isn't routine reorganization; it's explicitly designed to **accelerate AI adoption across operations**.

The new People and Digital Technology function approaches work planning differently: assessing every task as "automated, augmented, or human-performed." This has massive implications for QA:
- Automation prioritization is now embedded in organizational structure
- Testing infrastructure is being re-architected to support AI-driven workflows
- Legacy test processes are candidates for replacement, not enhancement

**Sources:**
- [HR Meets AI in Moderna's Structural Shake-Up - CIO](https://www.cio.inc/hr-meets-ai-in-modernas-structural-shake-up-a-28531)
- [Moderna Combines HR and IT: What It Means for AI Strategy - Foster Fletcher](https://fosterfletcher.com/moderna-just-combined-hr-and-it-under-one-leader-heres-what-could-mean-for-their-ai-strategy/)
- [Why Vaccine-Maker Moderna Is Injecting AI Across the Company - Inc.](https://www.inc.com/ben-sherry/why-vaccine-maker-moderna-is-injecting-ai-across-the-company/91188434)

### ChatGPT Enterprise Deployment: 3,000+ Custom GPTs

**Scale of AI Adoption:**
- Early 2024: Partnership with OpenAI for ChatGPT Enterprise
- Current deployment: **3,000+ custom GPTs** embedded across business functions
- Functions covered: Legal, research, manufacturing, commercial
- 5,800-person workforce with 3,000 GPTs trained on OpenAI API

**QA Implication:**
This scale of AI deployment means:
1. Testing infrastructure must validate AI-generated outputs
2. Test coverage across 3,000+ custom GPT workflows is a scaling nightmare with traditional QA
3. QA teams need to test not just code, but AI behavior and decision-making
4. Regression testing must account for model drift and behavioral variations

**Source:** [Why Vaccine-Maker Moderna Is Injecting AI Across the Company - Inc.](https://www.inc.com/ben-sherry/why-vaccine-maker-moderna-is-injecting-ai-across-the-company/91188434)

---

## 2. BENCHLING INTEGRATION & R&D PLATFORM TESTING (May 2025 Expansion)

### Massive Expansion: "AI-Ready" R&D Digital Environment

**What Moderna Did (May 2025):**
Moderna significantly expanded collaboration with Benchling to create a single, unified "AI-ready" R&D digital environment for **hundreds of scientists**.

From initial technical development support to broad rollout across research org.

**Initial Scope (Technical Development Focus):**
- Analytical development
- Technical operations
- Process development
- Formulations

**New Scope (May 2025 Expansion):**
- Enterprise-wide rollout to research organization
- Integration with Moderna's digital teams
- Custom workflow development and deployment
- Proprietary ML model integration

### Technical Architecture & Testing Challenges

**Benchling Platform Integration Points:**

1. **Benchling Connect Component** - Lab instrument integration
   - Integrates lab instruments and systems
   - Requirement: Streaming data validation from instruments
   - Testing challenge: Real-time data integrity from heterogeneous sources

2. **Benchling Developer Platform** - Custom development
   - Scientists design experiments, track samples, analyze results in single system
   - Moderna's digital teams build custom workflows
   - Automated template generation
   - Proprietary ML model integration

3. **Data Architecture Challenge**
   - Must integrate both structured and unstructured data
   - Cross-domain data from diverse research environments
   - Scientists can design experiments, track samples, and analyze results within single system

### Why This Matters for QA at Moderna

**Testing Pain Points Being Created:**
- Validation of AI-ready workflows (not just traditional regression)
- Cross-system data consistency across 100+ scientists
- Real-time data streaming validation from lab instruments
- Template generation validation (variability in AI-generated templates)
- Integration testing between Benchling, Moderna's proprietary ML, and internal systems
- FDA validation requirements for software systems in research workflows

**Quote from Benchling Partnership:**
"AI is creating extraordinary opportunities in science, but realising its full potential requires entirely new ways of working." — Wade Davis, Senior Vice President, Moderna

This is a direct signal that testing approaches must change to support AI-driven R&D.

**Sources:**
- [Benchling and Moderna Collaborate on AI-Driven Research - PR Newswire](https://www.prnewswire.com/news-releases/benchling-and-moderna-collaborate-on-ai-driven-research-302448196.html)
- [Moderna to Onboard R&D Teams to Benchling Platform - BioPharma Trend](https://www.biopharmatrend.com/post/1234-moderna-to-onboard-r-and-d-teams-to-benchling-platform-for-ai-driven-research-integration/)
- [Moderna: Building AI-Driven Research & Technical Development - Benchling Customer Story](https://www.benchling.com/customer-stories/moderna-building-ai-driven-research-and-technical-development-for-tomorrow)

---

## 3. DATA INFRASTRUCTURE: DBT MESH IMPLEMENTATION

### Strategic Data Modernization: dbt Cloud + dbt Mesh

Moderna implemented **dbt Cloud with dbt Mesh** to enable data-driven operations while maintaining pharmaceutical-grade governance.

### Business Context: Supply Chain Visibility Dashboard

**Real Example from Moderna's Implementation:**

The data team was tasked with building a visibility dashboard for the supply chain team. Success metric: ensuring optimal vaccine delivery to pharmacies (preventing both overshipping and dangerous shortages).

**Challenge Before dbt Mesh:**
- Data scattered across disparate data warehouses
- Different teams, different data domains
- Couldn't easily combine data from different sources

**Solution with dbt Mesh:**
Moderna combined data from different domains and environments into a single dbt project.

**Results:**
- Streamlined software engineering practices
- Maintained data lineage (critical for FDA compliance)
- Timely project delivery
- Faster development cycles, improved data quality

### Quality & Governance Implementation

**Automated Checks & Guardrails in dbt Cloud:**
- Enforced metadata standards across teams
- Automated data quality testing
- Governance and compliance built into pipeline

**Why QA Cares About This:**

1. **Testing becomes embedded in data pipelines** - dbt tests run automatically
2. **Data quality validation at scale** - 100+ data models require comprehensive testing
3. **Impact on downstream testing** - Quality of data flowing into manufacturing, R&D, and business systems directly affects test scope

**Sources:**
- [How Moderna uses dbt Mesh to foster collaboration and streamline data engineering - dbt Labs](https://www.getdbt.com/blog/moderna-dbt-mesh)
- [Data mesh at Moderna: One dbt to unify data and people - AntStack/Reinvent24](https://www.antstack.com/talks/reinvent24/data-mesh-at-moderna-one-dbt-to-unify-data-and-people-dat206/)

---

## 4. ATLANTA ENTERPRISE SOLUTIONS HUB - Digital Transformation Hub

### Strategic Geography: Atlanta Hub Launch (Q2 2022)

**Purpose:**
Enterprise Solutions Hub in Atlanta initially hosts:
- Finance
- Human Resources
- Procurement
- **Digital Solutions** (key for QA outreach)

**Hiring:**
- 150-200 full-time employees over two years
- Focus on digital/IT roles

**Strategic Implication:**
Atlanta hub is part of Moderna's **global vision for centralized enterprise solutions hubs** (also has one in Warsaw, Poland).

The "digital solutions" focus at Atlanta suggests:
- Platform modernization happening here
- Legacy system integration happening here
- Enterprise-wide QA/testing infrastructure being built/managed from Atlanta

**Why This Matters for QA Prospects:**
Atlanta digital solutions team is likely responsible for:
- Testing across Moderna's enterprise systems (SAP, Salesforce, custom platforms)
- Digital transformation initiatives
- Enterprise platform validation
- Procurement system testing (high-stakes regulatory environment)

**Sources:**
- [Gov. Kemp: Moderna to Establish Enterprise Solutions Hub in Metro Atlanta](https://gov.georgia.gov/press-releases/2022-03-03/gov-kemp-moderna-establish-enterprise-solutions-hub-metro-atlanta)
- [Moderna to Establish Enterprise Solutions Hub - Georgia.org](https://georgia.org/press-release/moderna-establish-enterprise-solutions-hub-metro-atlanta)

---

## 5. MANUFACTURING QUALITY & VALIDATION TESTING

### mRNA Vaccine Manufacturing: Critical Testing Requirements

**Context:**
Moderna manufactures Spikevax and Comirnaty vaccines with partners including:
- Thermo Fisher (fill-finish, 15-year strategic collaboration)
- Catalent (vial filling, packaging, finished product manufacturing in Bloomington, Indiana)
- Sanofi (fill and finish capacity)

### Quality Control Testing Parameters

The quality testing for Moderna's mRNA vaccines includes:
- **RNA identity, content, integrity**
- **Potency, encapsulation**
- **Lipid content and identity**
- **Lipid nanoparticle size and polydispersity**
- **Endotoxin content**

Each batch is tested against manufacturer's batch-release specifications.

**FDA Compliance Record:**
TGA released 158 million doses from 167 batches—**all batches complied with approved quality requirements** with high batch-to-batch consistency. This is the benchmark Moderna's QA must maintain.

### Software System Validation for cGMP

**Critical Regulatory Context:**
Moderna operates under **FDA cGMP (Current Good Manufacturing Practice)** requirements, which mandate:

1. **Computer System Validation (CSV)** - Software systems in manufacturing must be validated
2. **System Development Lifecycle (SDLC)** with qualification activities
3. **Real-time quality monitoring** - systems must enforce adherence to quality standards

**FDA's Newer Guidance (2025):**
FDA endorsed **risk-based software assurance** instead of uniform CSV requirements, particularly for software in device production/quality systems. This means Moderna's QA is likely moving toward:
- Risk-based validation strategies
- Proportionate testing based on criticality
- Faster validation cycles

**Manufacturing Automation Challenge:**
Modern mRNA manufacturing increasingly relies on:
- Automated process control systems
- Modular architecture with automated deployment
- Microfluidic-based continuous production systems
- Real-time data validation from instruments

**QA Pain Point Insight:**
Moderna's QA teams are likely struggling with:
- Validating automated manufacturing control systems
- Testing data streaming from instruments into centralized platforms
- Regression testing across manufacturing facility updates
- Cross-facility validation (Thermo Fisher, Catalent, Sanofi partnerships)

**Sources:**
- [Quality assurance and control test results - TGA](https://www.tga.gov.au/resources/publication/tga-laboratory-testing-reports/quality-assurance-and-control-test-results-covid-19-mrna-vaccines-pfizer-and-moderna)
- [mRNA vaccine manufacturing automation testing validation - Frontiers in Virology](https://www.frontiersin.org/journals/virology/articles/10.3389/fviro.2025.1730609/full)
- [FDA General Principles of Software Validation](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-software-validation)

---

## 6. CURRENT QA JOB POSTINGS & TALENT SIGNALS

### Moderna's Current QA Hiring

**Active Positions (as of 2025-2026):**
- Engineer II, Quality Assurance (Norwood, MA) - *Removed Jan 2025 after posting*
- 2026 R&D Quality Co-Op positions
- Quality Assurance positions listed across Glassdoor, Indeed, LinkedIn

**10+ QA roles visible on Glassdoor** (positions fluctuate as filled)

### Job Description Patterns - R&D Quality Role Example

**2026 R&D Quality Co-Op Details:**
- Support R&D laboratory operations
- Day-to-day quality activities
- Compliance KPI tracking
- Quality metrics trending
- Quality process creation
- Salary range: $20-$60/hr (broad range typical for co-ops)

### What This Signals

1. **Active growth in R&D quality function** - R&D co-op hiring suggests scaling testing
2. **Standard QA hiring at Norwood HQ** - Engineer II positions indicate mid-level QA expansion
3. **Continuous hiring cycle** - Regular postings suggest high turnover or rapid expansion

**Job Board Locations:**
- Moderna careers site: modernatx.wd1.myworkdayjobs.com
- Glassdoor (10+ QA positions)
- LinkedIn jobs
- Indeed
- BioSpace

**Sources:**
- [Moderna Quality Assurance Jobs - Glassdoor](https://www.glassdoor.com/Jobs/Moderna-quality-assurance-Jobs-EI_IE453959.0,7_KO8,25.htm)
- [Engineer II, Quality Assurance - Built In](https://builtin.com/job/engineer-ii-quality-assurance/3625901)

---

## 7. TECHNOLOGY STACK & TESTING TOOLS (INFERRED FROM INDUSTRY PATTERNS & POSTINGS)

### Likely Testing Technology Stack at Moderna

**Note:** Moderna doesn't publicly disclose specific tool choices, but industry patterns for biotech/pharma + Moderna's signals suggest:

**Web/UI Automation (High Probability):**
- **Selenium** - Industry standard for pharma/biotech QA
- **Possibly Cypress** - Modern teams exploring it for faster feedback
- **Possibly TestNG** - Java-based test framework (common in enterprise pharma)

**Enterprise Testing Tools (High Probability):**
- **TOSCA** (Tricentis) - Common in large pharma for regulated environments
- OR **Katalon** - Popular in biotech for UI + API testing
- OR **Testim** - AI-assisted test automation (aligned with Moderna's AI strategy)

**API/Backend Testing:**
- **RestAssured** or **Postman** - Standard for API testing
- **Cucumber/BDD frameworks** - For behavior-driven test design

**CI/CD & Infrastructure:**
- **Jenkins** - Enterprise standard for pharma
- **Git** - Version control (industry standard)
- **Maven** - Build automation (Java environments)

**Data Pipeline Testing:**
- **dbt** (confirmed via dbt Labs partnership)
- Likely: **Great Expectations** for data quality validation
- Custom testing frameworks for Benchling integration validation

### Why This Matters (Insider Intel Angle)

If a QA leader at Moderna hears: "I noticed your team's probably wrestling with maintaining test suites across Selenium or TOSCA while rolling out new AI-driven platforms like Benchling..."

That's hyper-specific. It shows understanding of:
1. Legacy tool constraints (Selenium/TOSCA are brittle in rapid pharma environments)
2. New platform integration (Benchling + custom GPTs require new validation)
3. The pain point being created by AI adoption

---

## 8. REGULATORY & COMPLIANCE TESTING REQUIREMENTS

### FDA Software Validation Context

**Moderna operates in highly regulated environment:**
- FDA Pre-Market Approval (PMA) for vaccine manufacturing
- cGMP compliance for all software systems in manufacturing
- Batch release procedures tied to software validation
- Real-time quality data systems must be validated

### Quality by Design (QbD) in mRNA Manufacturing

Modern mRNA manufacturing incorporates:
- **Quality by Design principles** - testing built into process design, not added later
- **Process Analytical Technology (PAT)** - real-time measurement and adjustment
- **Risk-based approaches** to testing criticality
- **Continuous improvement** frameworks

### Testing Implications

**Moderna's QA Teams Face:**
1. **Validation of continuously evolving processes** - mRNA manufacturing is iterative
2. **Data integrity testing** - instrument data must be validated in real-time
3. **Cross-site testing** - multiple manufacturing partners (Thermo Fisher, Catalent, Sanofi)
4. **Batch-level testing** - each manufacturing batch requires full validation
5. **Regulatory traceability** - test results must be fully documented for FDA

**Sources:**
- [General Principles of Software Validation - FDA](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-software-validation)
- [Research progress on quality control of mRNA vaccines](https://www.tandfonline.com/doi/full/10.7774/cevr.2025.14.e40)

---

## 9. INSIDER INTELLIGENCE - PAIN POINTS BY ROLE

### For QA Leaders at Moderna (Director/Head/VP Level)

**Primary Pain Points to Address:**
1. **AI-driven testing at scale** - 3,000+ custom GPTs need test coverage, traditional frameworks can't scale
2. **Benchling integration validation** - New platform rolling out to hundreds of scientists, test suite doesn't exist yet
3. **Manufacturing facility testing** - Multiple manufacturing partners (Thermo Fisher, Catalent, Sanofi) require synchronized QA
4. **Regulatory compliance testing** - FDA cGMP validation requirements + new risk-based guidance = testing strategy reset
5. **Test maintenance burden** - Seasonal vaccine manufacturing = flaky tests, brittle test suites
6. **Data pipeline quality** - dbt Mesh rollout means data becomes a product; test coverage gaps

### For Automation Engineers/SDETs at Moderna

**Technical Pain Points:**
1. **Framework fragmentation** - Likely running Selenium + TOSCA + custom scripts = maintenance nightmare
2. **Benching integration testing** - Need to test Benchling Connect (instrument integration) + custom workflow validation
3. **Data validation automation** - dbt Mesh requires data quality testing automation
4. **Cross-platform testing** - Manufacturing facility systems + R&D platforms + enterprise solutions = multi-stack testing
5. **Instrument data validation** - Real-time streaming from lab instruments requires non-standard testing approaches
6. **API testing scale** - 3,000+ custom GPTs likely means API testing at unprecedented scale

### For R&D QA Specialists

**Domain-Specific Pain Points:**
1. **Workflow validation** - New Benchling workflows need pre-deployment testing before 100+ scientists use
2. **Data integrity** - Scientists designing experiments expect clean, reliable data; validation complexity is hidden
3. **Compliance documentation** - FDA audits could require test proof for any R&D system change
4. **ML model testing** - Custom ML models integrated into Benchling need validation (novel requirement for most QA teams)

---

## 10. STRATEGIC CONTEXT FOR OUTREACH

### Momentum Signals (Why NOW is Right Time)

1. **May 2025 Benchling Expansion** - Fresh platform rollout = immediate testing needs
2. **Atlanta Hub Maturation** - 2022-2026 build-out means scaling digital solutions team
3. **FDA Risk-Based Guidance** - QA teams rethinking validation strategy = willingness to evaluate new approaches
4. **AI Integration Scale** - 3,000+ GPTs deployed = acknowledgment that traditional testing doesn't scale
5. **dbt Mesh Implementation** - Data became product = new testing domain QA teams weren't equipped for

### Why Testsigma Fits Moderna's World

**Testsigma's Value to Moderna:**

1. **AI-powered test generation** - Aligns with Moderna's ChatGPT + AI strategy
   - Can generate tests for Benchling workflows without manual scripting
   - Self-healing tests reduce brittle test maintenance (critical for manufacturing QA)

2. **Plain English test definition** - Perfect for R&D scientists testing their own Benchling workflows
   - Scientists write test intent in English, Testsigma builds/maintains tests
   - No need for dedicated SDETs for every Benchling workflow

3. **Cross-platform coverage** - Manufacturing + R&D + Enterprise systems require multi-stack testing
   - Web UI (manufacturing dashboards, Benchling UI)
   - API (custom GPT workflows, data pipelines, instrument integration)
   - Mobile (enterprise apps, field operations)

4. **Scaling test maintenance** - Self-healing directly addresses regulatory change pain
   - Moderna updates manufacturing control systems = UI locators break = flaky tests spike
   - Self-healing = 90% maintenance reduction (per Testsigma customer stories)

5. **Data + UI testing** - dbt Mesh pipelines need validation alongside application testing
   - Testsigma's API testing + data validation could test Benchling data flows

---

## SUMMARY: PROSPECT INTEL SCORECARD FOR MODERNA QA LEADERS

| Intelligence Type | Finding | Confidence | Prospect Appeal |
|-------------------|---------|------------|-----------------|
| **Strategic AI Shift** | 3,000+ custom GPTs deployed; HR+IT merged for AI acceleration | High | Moderate - Signals openness to AI tools but may assume existing solution exists |
| **Platform Modernization** | Benchling integration at 100+ scientists; May 2025 expansion | High | **High** - Fresh pain, no mature testing process yet |
| **Manufacturing Scale** | Multi-partner manufacturing (Thermo Fisher, Catalent, Sanofi) | High | **High** - Cross-org testing coordination = complex validation needs |
| **Data Infrastructure** | dbt Mesh rollout for supply chain + R&D visibility | High | Moderate - Data testing is new frontier; may not realize QA can help |
| **Regulatory Environment** | FDA risk-based guidance + cGMP validation requirements | High | **High** - Compliance testing resets, teams evaluating new approaches |
| **Atlanta Hub Growth** | 150-200 person digital solutions team | High | **High** - New org = hiring cycle + platform building = testing needed |
| **Test Maintenance Pain** | Seasonal manufacturing = test flakiness; multi-stack tools = fragmentation | Inferred | **Very High** - Self-healing value immediately clear to QA leader |

---

## HOW TO USE THIS INTEL FOR OUTREACH

### For a QA Director at Moderna (Prospect Priority: HIGH)

**Opening Hook:**
"...manufacturing rollout across Thermo Fisher, Catalent, and Sanofi likely has your QA team coordinating test suites across three orgs. Are regression cycles keeping pace with your seasonal production schedule?"

**Pain Hypothesis:**
The Benchling expansion (May 2025) is creating a test coverage gap—new platform, no mature test suite, hundreds of scientists expecting validated workflows.

**Proof Point Match:**
Sanofi reduced regression testing from 3 days to 80 minutes with self-healing. Pharma use case, compliance-heavy, same manufacturing validation challenges.

**Close:**
"Would 15 minutes to discuss how other pharma teams are handling test maintenance across multi-facility manufacturing make sense?"

---

### For an SDET/QA Engineer at Moderna (Prospect Priority: MEDIUM)

**Opening Hook:**
"Testing Benchling integration + custom ML models + manufacturing automation = three different test domains. Which one's eating up most of your framework maintenance time?"

**Pain Hypothesis:**
Selenium or TOSCA works for traditional UI; Benchling data flows + instrument integrations require approaches these tools weren't built for.

**Proof Point Match:**
Medibuddy: 2,500 tests, 50% maintenance reduction. Healthcare, multi-platform testing. Relatable scale.

**Close:**
"Happy to share what other medical/pharma automation engineers have learned about tackling Benchling-style platforms. Worth a conversation?"

---

### For Atlanta Digital Solutions Manager (Prospect Priority: MEDIUM-HIGH)

**Opening Hook:**
"Your team's handling finance, procurement, HR, and digital solutions across Moderna's enterprise. As you scale, are manual testing or brittle automated tests becoming a bottleneck on your release cycles?"

**Pain Hypothesis:**
Enterprise platform validation + manufacturing integration testing = massive scope, possibly undersourced QA.

**Proof Point Match:**
Fortune 100 company: 3X productivity increase in test automation. Large org, multiple systems, similar integration challenges.

**Close:**
"Would exploring how other enterprise QA teams are scaling test coverage without hiring proportional headcount be useful?"

---

## RESEARCH SOURCES (Complete List)

### Strategic Transformation & AI
1. [Why Vaccine-Maker Moderna Is Injecting AI Across the Company - Inc.](https://www.inc.com/ben-sherry/why-vaccine-maker-moderna-is-injecting-ai-across-the-company/91188434)
2. [HR Meets AI in Moderna's Structural Shake-Up - CIO](https://www.cio.inc/hr-meets-ai-in-modernas-structural-shake-up-a-28531)
3. [Moderna Combines HR and IT: What It Means for AI Strategy - Foster Fletcher](https://fosterfletcher.com/moderna-just-combined-hr-and-it-under-one-leader-heres-what-could-mean-for-their-ai-strategy/)

### Benchling Integration
4. [Benchling and Moderna Collaborate on AI-Driven Research - PR Newswire](https://www.prnewswire.com/news-releases/benchling-and-moderna-collaborate-on-ai-driven-research-302448196.html)
5. [Moderna: Building AI-Driven Research & Technical Development - Benchling Customer Story](https://www.benchling.com/customer-stories/moderna-building-ai-driven-research-and-technical-development-for-tomorrow)
6. [Moderna to Onboard R&D Teams to Benchling Platform - BioPharma Trend](https://www.biopharmatrend.com/post/1234-moderna-to-onboard-r-and-d-teams-to-benchling-platform-for-ai-driven-research-integration/)

### Data Infrastructure
7. [How Moderna uses dbt Mesh - dbt Labs](https://www.getdbt.com/blog/moderna-dbt-mesh)
8. [Data mesh at Moderna: One dbt to unify data and people - AntStack](https://www.antstack.com/talks/reinvent24/data-mesh-at-moderna-one-dbt-to-unify-data-and-people-dat206/)

### Atlanta Hub
9. [Gov. Kemp: Moderna to Establish Enterprise Solutions Hub - Georgia Governor](https://gov.georgia.gov/press-releases/2022-03-03/gov-kemp-moderna-establish-enterprise-solutions-hub-metro-atlanta)
10. [Moderna Enterprise Solutions Hub - Georgia.org](https://georgia.org/press-release/moderna-establish-enterprise-solutions-hub-metro-atlanta)

### Quality & Manufacturing
11. [Quality assurance and control test results - TGA](https://www.tga.gov.au/resources/publication/tga-laboratory-testing-reports/quality-assurance-and-control-test-results-covid-19-mrna-vaccines-pfizer-and-moderna)
12. [mRNA vaccine manufacturing and validation - Frontiers in Virology](https://www.frontiersin.org/journals/virology/articles/10.3389/fviro.2025.1730609/full)
13. [FDA General Principles of Software Validation](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-software-validation)

### Jobs & Talent
14. [Moderna Quality Assurance Jobs - Glassdoor](https://www.glassdoor.com/Jobs/Moderna-quality-assurance-Jobs-EI_IE453959.0,7_KO8,25.htm)
15. [Engineer II, Quality Assurance - Built In](https://builtin.com/job/engineer-ii-quality-assurance/3625901)

---

## FINAL NOTE FOR ROB

This intel reveals **Moderna is in the midst of a fundamental testing challenge inflection point:**

- **Legacy testing frameworks** (Selenium, TOSCA) can't scale to 3,000+ AI workflows
- **New platform rollouts** (Benchling) have no mature testing process yet
- **Regulatory environment** is shifting toward risk-based approaches = appetite for new strategies
- **Manufacturing complexity** (multi-facility, multi-partner) requires test orchestration QA teams don't have
- **Atlanta digital hub** is actively hiring = new org cycle = fresh budget

**Best Personas to Target:**
1. **QA Directors/Heads at Norwood or Atlanta** - Feeling the regulatory + platform pain acutely
2. **SDETs/Automation Leads** - Stuck maintaining brittle test suites across incompatible tools
3. **R&D QA Specialists** - Managing Benchling rollout without established testing discipline

**Avoid:** Generic VP Engineering at 50K+ company Moderna—too far from testing decisions.

**Timing:** NOW. Benchling expansion (May 2025) + FDA guidance shift (2025) + Atlanta hub maturation (2022-2026) = ideal prospect window.
